Has John Byers received payments from drug or device companies?

Yes. Drug and device makers reported $2,499 in general payments to John Byers across 132 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Byers did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Byers come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Byers

Internal Medicine · Fort Moore, GANPI 1245331313

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,411 and has fallen 96.5% since, to $49 in 2023.

$2,499in general payments, 2019–2025

Across 132 payments — averaging $18.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$494
Novartis$323
Medtronic$299
Amgen$279
Boston Scientific$231
Abbott$181
plus $692 from 14 others

What the payments were for

Food & beverage$2,499100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	31	$494
Novartis	24	$323
Medtronic	3	$299
Amgen	18	$279
Boston Scientific	2	$231
Abbott	6	$181
Pfizer	15	$177
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	11	$139
Sanofi-aventis U.S. LLC	5	$95
Esperion Therapeutics, Inc.	3	$46
Irhythm Technologies, Inc.	2	$44
Gilead	3	$43
Abiomed	2	$33
Cardiva Medical, Inc.	1	$20
Amarin Pharma, Inc.	1	$19
Astellas Pharma US Inc	1	$17
Philips North America LLC	1	$17
Atricure, Inc.	1	$17
Boehringer Ingelheim	1	$13
Regeneron Healthcare Solutions, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,499 in reported general payments places this provider in the 80th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia →

Other internal medicine in Fort Moore

Michael GibsonSmyrna$2.2M
Eduard FatakhovAlpharetta$376K
Tracey HenryAtlanta$305K
Sharon TuckettVilla Rica$265K
Ebon BourneMarietta$242K
Jennifer WoehlerSavannah$207K
Julian HutchinsGreensboro$201K
Brian PearlmanDalton$199K
Scott ParryAtlanta$162K
Jennifer GilliganAtlanta$162K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →